Report second interim data analysis from the MRT5005 Phase 1/2 cystic fibrosis trial
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 25 Feb 2021
- Due
- 30 Jun 2021
- Delivered
- March 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Completed dosing in cohorts for the second interim data analysis, which is expected to be reported in early Q2 2021.”
What we found
Evidence strength A What the grades mean
Later 10-Q filings state the company reported the second interim data analysis in March 2021, before the end-of-Q2 2021 deadline.
-
A Translate Bio, Inc. 10-Q filed 2021-05-06
“in March 2021, the Company reported the second interim data analysis” ✓ confirmed on the page
-
A Translate Bio, Inc. 10-Q filed 2021-05-06
“During the quarter ended March 31, 2021, the Company released results of the second interim data analysis from the Phase 1/2 clinical trial of MRT5005.” ✓ confirmed on the page
-
A Translate Bio, Inc. 10-Q filed 2021-08-05
“In March 2021, the Company reported the second interim data analysis.” ✓ confirmed on the page
Checked 26 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Report
- Deliverable
- Interim data from MRT5005 Phase 1/2 CF trial
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- Medium
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Translate Bio, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C693415-024501 · Corrections policy